Bedside testing of CYP2C19 gene for treatment of patients with PCI with antiplatelet therapy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2261
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Bedside testing of CYP2C19 gene for treatment of patients with PCI with antiplatelet therapy ; volume:20 ; number:1 ; day:3 ; month:6 ; year:2020 ; pages:1-9 ; date:12.2020
BMC cardiovascular disorders ; 20, Heft 1 (3.6.2020), 1-9, 12.2020
- Urheber
-
Al-Rubaish, Abdullah M.
Al-Muhanna, Fahad A.
Alshehri, Abdullah M.
Al-Mansori, Mohammed A.
Alali, Rudaynah A.
Khalil, Rania M.
Faraidy, Khalid A. Al
Cyrus, Cyril
Sulieman, Mohammed M.
Vatte, Chittibabu
Claassens, Daniel M. F.
Berg, Jurriën M. ten
Asselbergs, Folkert W.
Al-Ali, Amein K.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12872-020-01558-2
- URN
-
urn:nbn:de:101:1-2020080502105151267574
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:50 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Al-Rubaish, Abdullah M.
- Al-Muhanna, Fahad A.
- Alshehri, Abdullah M.
- Al-Mansori, Mohammed A.
- Alali, Rudaynah A.
- Khalil, Rania M.
- Faraidy, Khalid A. Al
- Cyrus, Cyril
- Sulieman, Mohammed M.
- Vatte, Chittibabu
- Claassens, Daniel M. F.
- Berg, Jurriën M. ten
- Asselbergs, Folkert W.
- Al-Ali, Amein K.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Novel Aspects of Antiplatelet Drug Therapy in Patients Undergoing Percutaneous Coronary Intervention : Antiplatelet Therapy in Patients Undergoing PCI
A pharmacodynamic comparison of 5 anti-platelet protocols in patients with ST-elevation myocardial infarction undergoing primary PCI
Duration of dual antiplatelet therapy for patients at high bleeding risk undergoing PCI
Prasugrel or ticagrelor relative to clopidogrel in triple-antiplatelet treatment combined with glycoprotein IIb/IIIa inhibitor for patients with STEMI undergoing PCI: a meta-analysis
Bedside and laboratory diagnostic testing in myasthenia
Outcome of PCI in Patients with LV Dysfunction
Outcomes After PCI in Patients with LV Dysfunction
Problems with Antiplatelet Therapy in Children with Cyanotic Heart Disease
Prevalence of antiplatelet therapy in patients with diabetes
Antiplatelet therapy with CABG: chaos in the Netherlands
Antiplatelet agents
Acute dizziness and vertigo: The bedside testing is essential
Novel Aspects of Antiplatelet Drug Therapy in Patients Undergoing Percutaneous Coronary Intervention : Antiplatelet Therapy in Patients Undergoing PCI
A pharmacodynamic comparison of 5 anti-platelet protocols in patients with ST-elevation myocardial infarction undergoing primary PCI
Duration of dual antiplatelet therapy for patients at high bleeding risk undergoing PCI
Prasugrel or ticagrelor relative to clopidogrel in triple-antiplatelet treatment combined with glycoprotein IIb/IIIa inhibitor for patients with STEMI undergoing PCI: a meta-analysis
Bedside and laboratory diagnostic testing in myasthenia
Outcome of PCI in Patients with LV Dysfunction
Outcomes After PCI in Patients with LV Dysfunction
Problems with Antiplatelet Therapy in Children with Cyanotic Heart Disease
Prevalence of antiplatelet therapy in patients with diabetes
Antiplatelet therapy with CABG: chaos in the Netherlands
Antiplatelet agents
Acute dizziness and vertigo: The bedside testing is essential
Novel Aspects of Antiplatelet Drug Therapy in Patients Undergoing Percutaneous Coronary Intervention : Antiplatelet Therapy in Patients Undergoing PCI
A pharmacodynamic comparison of 5 anti-platelet protocols in patients with ST-elevation myocardial infarction undergoing primary PCI
Duration of dual antiplatelet therapy for patients at high bleeding risk undergoing PCI
Prasugrel or ticagrelor relative to clopidogrel in triple-antiplatelet treatment combined with glycoprotein IIb/IIIa inhibitor for patients with STEMI undergoing PCI: a meta-analysis
Bedside and laboratory diagnostic testing in myasthenia
Outcome of PCI in Patients with LV Dysfunction
Outcomes After PCI in Patients with LV Dysfunction
Problems with Antiplatelet Therapy in Children with Cyanotic Heart Disease
Prevalence of antiplatelet therapy in patients with diabetes
Antiplatelet therapy with CABG: chaos in the Netherlands
Antiplatelet agents